Folic Acid
In clinical developmentAlso known as Acide folique, Acidum folicum, Anemagen, Animi-3+104 more
Acide folique, Acidum folicum, Anemagen, Animi-3, Animi-3 with Vitamin D, BiferaRx, Calafol Rx, Concept OB, Dialyvite 800, Dialyvite 800 + Iron, Dialyvite 800 with Iron, Dialyvite 800 with Zinc, Duleek-DP, Ed Cyte F, Encora AM Tablet, Encora PM Tablet, Equi-Cyte F, FA - Folic acid, FA-8, Feogen, Ferocon, Ferotrin, Ferotrinsic, Ferralet 90, Ferraplus, Ferrex 150 Forte, Ferrex 150 Forte Plus, Ferrocite F, Ferrocite Plus, Ferrogels Forte, Folacin, Folbalin, Folbecal, Folbee, Folbic, Folcaps, Folditam, Foleve, Folgard, Folgard OS, FoliNatal Plus B, Folitab, Folivane-F, Folnate, Folpace Rx, Folplex, Folsäure, Foltabs, Foltrate, Foltx, Hematogen, Hemax, Hemocyte Plus, Hemocyte-F, Hemocyte-F Elixir, Icar-C Plus, Iferex 150 Forte, Infuvite, Infuvite Pediatric, Integra F, Ircon-FA, Irofol, Irospan Tablet, Lactobacillus casei factor, Lactocal, MTX Support, MVC-Fluoride, MagneBind 400 Rx, Mi-Omega, Multigen Plus, N-pteroyl-L-glutamic acid, Natafort, Natelle, Nephro-Fer RX, Nephrocaps, Nephrocaps QT, NicAzel, Nicomide, Niferex-150 Forte, Niva-Fol, NuFol, Poly Iron 150 Forte, PreNexa, Pregnitude, Premesis Rx, Prenatal Rx 1, PteGlu, Pteroyl-L-glutamate, Pteroyl-L-glutamic acid, Pteroyl-L-monoglutamic acid, Pteroylglutamic acid, Pteroylmonoglutamic acid, Quiofic, Rena-Vite, Slow Fe with Folic Acid, Tandem F, Tandem OB, Tandem Plus, Vita-Respa, Vitabee with C, Vitafol-One, Vitamin B-9, Vitamin B9, Vitamin B>c<, Vitamin Bc, Vitamin M, ácido fólico, Folic-acid.
Recent clinical, regulatory, research and industry developments relating to this drug.
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease
A Study of Serum Folate Levels in Patients With Treated With Olaparib.
Folate Receptor Alpha-A Novel Approach to Cancer Therapy.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- International journal of molecular sciences2
- Annual review of neuroscience1
- Nutrients1
- The New England journal of medicine1
- Arnold MJ1
- Barbosa DJ1
- Copp AJ1
- Cunha A1
- Fodor G1
- Genest J Jr1
- Gil-Martins E1
- Gonzalez T1
- Associate Laboratory i4HB-Institute for Health and Bioeconomy1
- Clinic for Adult Psychiatry1
- Laboratory of Toxicology1
- Memorial Cancer Institute1
- Newlife Birth Defects Research Center1
- Population Health Research Institute1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 6 of the same disease areas as Folic Acid in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials